Clinical Trial Update: DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial [EARLY_Phase 1]

View source ↗

Summary

Clinical trial entry describing a Phase 1 pilot study comparing direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation who…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• Eliquis (apixaban)
• Lixiana (edoxaban)
• Pradaxa (dabigatran etexilate)
• Warfarin (warfarin)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Population Health Research Institute | Conditions: Atrial Fibrillation (AF), Stroke (in Patients With Atrial Fibrillation) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING